Connect Biopharma Holdings Limited
CNTB
$2.05
-$0.10-4.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.57% | 11.74% | 0.00% | -178.39% | 270.79% |
| Total Depreciation and Amortization | -1.16% | 88.04% | 0.00% | -43.21% | -1.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.80% | -71.23% | 0.00% | 27.69% | 61.29% |
| Change in Net Operating Assets | 10.39% | -148.90% | 0.00% | 104.86% | -467.80% |
| Cash from Operations | -26.43% | -27.37% | 0.00% | -1.61% | -1,202.03% |
| Capital Expenditure | -274.07% | 48.41% | 0.00% | 45.86% | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 126.42% | -166.80% | 0.00% | -320.20% | -62.16% |
| Cash from Investing | 124.85% | -162.47% | 0.00% | -344.98% | -65.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00% | -- | -- |
| Issuance of Common Stock | 7,950.00% | -96.80% | 0.00% | -48.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,950.00% | -98.53% | 0.00% | 12.81% | -- |
| Foreign Exchange rate Adjustments | 198.67% | 129.70% | 0.00% | -347.55% | 146.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.81% | -93.20% | 0.00% | -270.69% | -150.51% |